FDA Approval of Cobenfy: A New Milestone in Schizophrenia Treatment Sub: Sci Sec: Health Why in News The U.S. Food and Drug Administration (FDA) recently approved Cobenfy, a novel antipsychotic drug designed to treat schizophrenia by targeting cholinergic receptors, making it the first of its kind. This breakthrough comes at a time when […]